1. Atwell S, Brouillette CG, Conners K, Emtage S, Gheyi T, Guggino WB, Hendle J, Hunt JF, Lewis HA, Lu F, Protasevich II, Rodgers LA, Romero R, Wasserman SR, Weber PC, Wetmore D, Zhang FF, Zhao X. (2010 May). Structures of a minimal human CFTR first nucleotide-binding domain as a monomer, head-to-tail homodimer, and pathogenic mutant. Protein Engineering, Design and Selection. 23(5):375-384. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20150177?dopt=Abstract. PubMed ID: 20150177.
2. Aleksandrov AA, Kota P, Aleksandrov LA, He L, Jensen T, Cui L, Gentzsch M, Dokholyan NV, Riordan JR. (2010 August 13). Regulatory insertion removal restores maturation, stability, and function of ?F508 CFTR. Journal of Molecular Biology. 401(2):194-210. Retrieved from: http://www.ncbi.nlm.nih.gov/pubmed/20561529. PubMed ID: 20561529.
3. Gadsby, DC, Vergani P, Csanady L. (2006 March 23). The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature. 440(7083):477-483. Retrieved from http://www.nature.com/nature/journal/v440/n7083/full/nature04712.html. PubMed ID: 16554808.
4. Lewis HA, Zhao, X, Wang C, Sauder JM, Rooney I, Noland BW, Lorimer D, Kearins MC, Conners K, Condron B, Maloney PC, Guggino WB, Hunt JF, Emtage S. (2005 January 14). Impact of the ?F508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding. Journal of Biological Chemistry. 280:1346-1353. Retrieved from http://www.jbc.org/content/280/2/1346.long. PubMed ID: 15528182.
5. Lewis HA, Wang C, Zhao X, Hamuro Y, Conners K, Kearins MC, Lu F, Sauder JM, Molnar KS, Coales SJ, Maloney PC, Guggino WB, Wetmore DR, Weber PC, Hunt JF. (2010 February 19). Structure and dynamics of NBD1 from CFTR characterized using crystallography and hydrogen/deuterium exchange mass spectrometry. Journal of Molecular Biology. 396(2):406-430. Retrieved from http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WK7-4XSVRKN-7&_user=709071&_coverDate=02%2F19%2F2010&_rdoc=1&_fmt=high&_orig=search&_origin=search&_sort=d&_docanchor=&view=c&_acct=C000039638&_version=1&_urlVersion=0&_userid=709071&md5=ef5cc1a8c60a89cfa601adb6f58bb7c7&searchtype=a. PubMed ID: 19944699
6. Muallem D, Vergani P. (2009 January 27). Review: ATP hydrolysis-driven gating in cystic fibrosis transmembrane conductance regulator. Philosophical Transactions of the Royal Society B: Biological Sciences. 364(1514):247-255. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674100/?tool=pubmed. PubMed ID: 18957373.
7. Procko, E, Ferrin-O?Connell I, Ng S, Gaudet R. (5 October 2006). Distinct structural and funcation properties of the ATPase sites in an asymmetric ABC transporter. Molecular Cell. 24(1):51-62. Retrieved from http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WSR-4M22K03-5&_user=709071&_coverDate=10%2F06%2F2006&_rdoc=1&_fmt=high&_orig=search&_origin=search&_sort=d&_docanchor=&view=c&_acct=C000039638&_version=1&_urlVersion=0&_userid=709071&md5=6d25ace584538e4deb465667f78c0b1f&searchtype=a. PubMed ID: 17018292.
8. Ramaen O, Leulliot N, Sizun C, Ulryck N, Pamlard O, Lallemand JY, Tilbeurgh H, Jacquet E. (2006 June 16). Structure of the human multidrug resistance protein 1 nucleotide binding domain 1 bound to Mg2+/ATP reveals a non-productive catalytic site. Journal of Molecular Biology. 359(4):940-949. Retrieved from http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WK7-4JVSSMT-1&_user=709071&_coverDate=06%2F16%2F2006&_rdoc=1&_fmt=high&_orig=search&_origin=search&_sort=d&_docanchor=&view=c&_acct=C000039638&_version=1&_urlVersion=0&_userid=709071&md5=5dddd2d3d26f633e2a29e3df33680f8f&searchtype=a. PubMed ID: 16697012.
9. Rosenburg MF, Kamis AB, Aleksandrov LA, Ford RC, Riordan JR. (2004 September 10). Purification and crystallization of the cystic fibrosis transmembrane conductance regulator (CFTR). The Journal of Biological Chemistry. 279(37):39501-7. Retrieved from http://www.jbc.org/content/279/37/39051.long. PubMed ID: 15247233.